Literature DB >> 18066559

MAPT S305I mutation: implications for argyrophilic grain disease.

Gabor G Kovacs1, Alan Pittman, Tamas Revesz, Connie Luk, Andrew Lees, Eva Kiss, Peter Tariska, Lajos Laszlo, Kinga Molnár, Maria J Molnar, Markus Tolnay, Rohan de Silva.   

Abstract

Frontotemporal lobar degeneration (FTLD) with mutations in the tau gene (MAPT) causes familial frontotemporal dementia with tau pathology. Many of these mutations result in morphological phenotypes resembling sporadic tauopathies, although, to date, no such cases mimicking argyrophilic grain disease (AgD) have been documented. We now present a case with a novel S305I MAPT mutation and a morphological phenotype showing resemblance to AgD. At the age of 39, the patient developed behavioural and personality changes and lack of verbal fluency with later poor performance on naming tasks and rigidity in the extremities. After a short disease course of 1.5 years, the patient died. A unique neuropathological phenotype with neuronal diffuse cytoplasmic tau immunoreactivity, oligodendroglial-coiled bodies, argyrophilic grains, and non-argyrophilic, but tau-immunopositive and ubiquitin-immunonegative pre-grains were observed, whereas classical neurofibrillary tangles, Pick bodies, and neuritic plaques were absent. The tau-positive abnormal structures were composed only of 4R-tau isoforms and, ultrastructurally, straight filaments. Neuronal loss was greatest in the medial temporal cortex, hippocampus, and amygdala. These pathological features resemble AgD. The novel S305I substitution has a strong effect on MAPT exon 10 splicing, thereby causing a striking increase in 4R-tau isoforms. Our observation not only widens the phenotypic spectrum of FTLD with MAPT mutation but also underpins the notion that the predominance of similar neuropathological findings in sporadic AgD cases may be viewed as features of a distinct disease entity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066559     DOI: 10.1007/s00401-007-0322-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.

Authors:  Marta Marquié; Marc D Normandin; Avery C Meltzer; Michael Siao Tick Chong; Nicolas V Andrea; Alejandro Antón-Fernández; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik Debnath; Elizabeth A Bien; Charles R Vanderburg; Isabel Costantino; Sara Makaretz; Sarah L DeVos; Derek H Oakley; Stephen N Gomperts; John H Growdon; Kimiko Domoto-Reilly; Diane Lucente; Bradford C Dickerson; Matthew P Frosch; Bradley T Hyman; Keith A Johnson; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2017-01       Impact factor: 10.422

Review 2.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 3.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

Review 4.  The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy.

Authors:  Cheng-Cheng Zhang; Ang Xing; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-09-12       Impact factor: 5.590

5.  Argyrophilic Grain Disease: Demographics, Clinical, and Neuropathological Features From a Large Autopsy Study.

Authors:  Roberta Diehl Rodriguez; Claudia Kimie Suemoto; Mariana Molina; Camila Fernandes Nascimento; Renata Elaine Paraizo Leite; Renata Eloah de Lucena Ferretti-Rebustini; José Marcelo Farfel; Helmut Heinsen; Ricardo Nitrini; Kenji Ueda; Carlos Augusto Pasqualucci; Wilson Jacob-Filho; Kristine Yaffe; Lea Tenenholz Grinberg
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-09       Impact factor: 3.685

6.  18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.

Authors:  David N Soleimani-Meigooni; Leonardo Iaccarino; Renaud La Joie; Suzanne Baker; Viktoriya Bourakova; Adam L Boxer; Lauren Edwards; Rana Eser; Maria-Luisa Gorno-Tempini; William J Jagust; Mustafa Janabi; Joel H Kramer; Orit H Lesman-Segev; Taylor Mellinger; Bruce L Miller; Julie Pham; Howard J Rosen; Salvatore Spina; William W Seeley; Amelia Strom; Lea T Grinberg; Gil D Rabinovici
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

7.  Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.

Authors:  Dietmar Rudolf Thal; Christine A F von Arnim; W Sue T Griffin; Robert E Mrak; Lauren Walker; Johannes Attems; Thomas Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2015-01-04       Impact factor: 3.575

8.  Structure-based classification of tauopathies.

Authors:  Yang Shi; Wenjuan Zhang; Yang Yang; Alexey G Murzin; Benjamin Falcon; Abhay Kotecha; Mike van Beers; Airi Tarutani; Fuyuki Kametani; Holly J Garringer; Ruben Vidal; Grace I Hallinan; Tammaryn Lashley; Yuko Saito; Shigeo Murayama; Mari Yoshida; Hidetomo Tanaka; Akiyoshi Kakita; Takeshi Ikeuchi; Andrew C Robinson; David M A Mann; Gabor G Kovacs; Tamas Revesz; Bernardino Ghetti; Masato Hasegawa; Michel Goedert; Sjors H W Scheres
Journal:  Nature       Date:  2021-09-29       Impact factor: 49.962

Review 9.  Tau at the interface between neurodegeneration and neuroinflammation.

Authors:  Alessandro Didonna
Journal:  Genes Immun       Date:  2020-10-03       Impact factor: 2.676

10.  Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia.

Authors:  Olga Kopach; Noemí Esteras; Selina Wray; Andrey Y Abramov; Dmitri A Rusakov
Journal:  Cell Death Dis       Date:  2021-07-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.